Inventor
PLANTEVIN-KRENITSKY VERONIQUE
US20 patents
⚠️ This page may combine multiple inventors who share the name “PLANTEVIN-KRENITSKY VERONIQUE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
11 patentsUS11149007B2Oct 19, 2021
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP14 citations84
US11325889B2May 10, 2022
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP11 citations83
US11634407B2Apr 25, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP5 citations73
US11873283B2Jan 16, 2024
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP2 citations71
US11739075B2Aug 29, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP3 citations71
US11560371B2Jan 24, 2023
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP3 citations71
US12404241B2Sep 2, 2025
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US12227490B2Feb 18, 2025
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US12103920B2Oct 1, 2024
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US11945804B2Apr 2, 2024
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations61
US11358952B2Jun 14, 2022
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP1 citations60
SIGNAL PHARM LLC
7 patentsUS7723340B2May 25, 2010
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC46 citations91
US7521446B2Apr 21, 2009
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC39 citations91
US9187479B2Nov 17, 2015
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC17 citations89
US9556126B2Jan 31, 2017
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC10 citations82
US9156798B2Oct 13, 2015
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC5 citations82
US9725450B2Aug 8, 2017
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC9 citations80
US9783505B2Oct 10, 2017
Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations71